HO
HELEN OF TROY LTD (HELE)·Q4 2025 Earnings Summary
Executive Summary
- Q4 FY2025 revenue was $485.9M, down 0.7% YoY, with adjusted diluted EPS of $2.33 (down 4.9% YoY); GAAP EPS rose 24% to $2.22 on a $64.6M transitional tax benefit despite a $51.5M Drybar impairment .
- Versus consensus, Q4 revenue beat ($485.9M vs $481.7M*) while adjusted EPS modestly missed ($2.33 vs $2.38*); adjusted EBITDA came in below the Street ($84.3M vs $87.9M*) .
- Management suspended FY2026 guidance due to rapidly changing global tariff actions, targeting <20% of COGS exposed to China tariffs by end FY2026 and planning to offset 70–80% of tariff impact via diversification, pricing, and cost moves .
- Operational positives: Wellness strength (flu spike, air purification demand), OXO and Osprey growth, and a better-than-expected Olive & June contribution ($23M) .
- Catalyst: withdrawal of FY2026 outlook and tariff mitigation plan (pricing, supplier diversification, China purchase freeze) drive near-term narrative, with Q1 implied softness and defensive cost posture highlighted on the call .
What Went Well and What Went Wrong
What Went Well
- Wellness outperformed expectations (late flu spike → stronger POS in Braun/Vicks; air purification demand tied to LA wildfires) and saw replenishment orders late in the quarter .
- OXO and Osprey posted growth; OXO gained market share and distribution, while Osprey maintained #1 position and expanded in lifestyle and kid carrier categories .
- Olive & June exceeded expectations with ~$23M revenue, strong gel system launches and retail expansion; included in Bain Insurgent Brand list and #1 nail brand at Target .
- CEO: “We reported fourth quarter net sales and adjusted diluted EPS that met the Outlook range…strength in Wellness, OXO, Osprey, and International…better-than-expected Olive & June” .
What Went Wrong
- Drybar impairment ($51.5M pre-tax; $47.6M after tax) drove GAAP operating margin down to 0.4% (vs 13.5% prior year); SG&A ratio rose 120 bps on acquisition costs and higher marketing .
- Organic declines: Beauty hair appliances and insulated beverageware pressured net sales (organic -4.9% consolidated), with competitive intensity and softer demand cited .
- Guidance visibility: FY2026 outlook withdrawn amid tariffs (management stepping back from long-term algorithm), Q1 flagged as particularly soft with retailers pausing direct imports from China .
Financial Results
Segment breakdown (Q4 YoY):
Key KPIs:
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “We are not in a position to provide fiscal ’26 guidance…we are also stepping back from the long-term algorithm we laid out at our Investor Day in October 2023.”
- CFO: “We believe we can offset 70% to 80% of the tariff impact in fiscal ’26 based on tariffs currently in place.”
- CEO: “We are leaning into areas of opportunity, including international…as well as value reframing across our portfolio.”
- CFO on Q1: “We’re expecting softness in Q1…retailers paused direct import orders from China…unfavorable impact on Q1 revenue.”
- CEO on brand health: “We implemented revitalized consumer and data-centric brand strategy…expanded distribution footprint globally…Pegasus contributed to a 60 bps increase in gross margin.”
Q&A Highlights
- Supplier diversification: Majority with existing suppliers; minority new; moves intended to be cost neutral excluding one-time CapEx, capability build, and inventory buffers .
- Pricing: Contemplated and targeted rather than across-the-board; item-level thresholds with retailer collaboration; Osprey currently less exposed .
- Tariff impact sizing: Directionally “over $200M” FY26 gross impact at current rates; with 70–80% mitigated via levers (supplier costs, pricing, spend adjustments) .
- Cash flow: Expect positive free cash flow for FY26 despite defensive posture .
- Demand outlook: Anticipate softer consumer environment; Q1 highlighted as seasonally weakest, compounded by retailer import pauses and China nationalism pressuring international revenue .
Estimates Context
- Q4 FY2025: Revenue beat ($485.9M vs $481.7M*), adjusted EPS slight miss ($2.33 vs $2.38*), adjusted EBITDA miss ($84.3M vs $87.9M*).
- Q3 FY2025: Adjusted EPS beat ($2.67 vs $2.58*), revenue slight miss ($530.7M vs $532.9M*), EBITDA near inline ($96.8M vs $95.0M*).
Values retrieved from S&P Global.*
Key Takeaways for Investors
- Near-term narrative is dominated by tariff uncertainty: no FY26 guidance, aggressive supply chain diversification, and contemplated pricing actions; expect Q1 to be weak as retailers pause China direct imports .
- Revenue quality improved in Wellness and International; Olive & June accelerates Beauty portfolio relevance and growth within nails, partially offsetting hair appliance softness .
- Margin compression (adjusted operating margin 15.4%, -160 bps YoY) reflects mix and higher growth investment; Pegasus savings continue but were not enough to offset mix and SG&A increases in Q4 .
- Balance sheet leverage increased to ~3x post Olive & June and buybacks; interest rate swaps provide visibility (81% fixed at ~3.7% FY26), supporting cash preservation strategy .
- Modeling FY26: Management targets <20% China COGS exposure by end FY26 and 70–80% tariff mitigation; consider scenario analysis on pricing elasticity and international shift to buffer U.S. tariff impact .
- Trading stance: Watch for tariff policy developments and retailer import behavior; sentiment likely hinges on visibility to mitigation timelines and early read on Q1 demand trajectory .
- Medium-term thesis: Portfolio revitalization (Drybar pipeline, OXO innovation, Osprey category expansion) plus international growth should re-accelerate as tariff mitigation lands and mix normalizes .
Notes:
* Values retrieved from S&P Global.